| # | Security | Value | Shares | % Port | Change | Δ Shares |
|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I COM NEW | $285.3M | 885.5K | 14.3% | REDUCED | -64,500 |
| 2 | BRIDGEBIO ONCOLOGY THERAPEUT COM NEW | $160.0M | 17.88M | 8.0% | —HELD | 0 |
| 3 | EYEPOINT INC COM NEW | $106.5M | 8.27M | 5.4% | —HELD | 0 |
| 4 | EDGEWISE THERAPEUTICS INC COM | $102.7M | 3.26M | 5.2% | REDUCED | -25,000 |
| 5 | ERASCA INC COM | $93.8M | 5.80M | 4.7% | NEW | — |
| 6 | RAPPORT THERAPEUTICS INC COM | $92.5M | 2.96M | 4.6% | REDUCED | -70,000 |
| 7 | ALUMIS INC COM | $87.0M | 3.95M | 4.4% | ADDED | +313.6K |
| 8 | ABIVAX SA SPONSORED ADS | $84.6M | 760.0K | 4.3% | REDUCED | -590,000 |
| 9 | MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | $83.5M | 4.48M | 4.2% | ADDED | +125.0K |
| 10 | DIANTHUS THERAPEUTICS INC COM | $79.7M | 950.0K | 4.0% | NEW | — |
| 11 | BRIGHT MINDS BIOSCIENCES INC COM NEW | $77.3M | 1.06M | 3.9% | —HELD | 0 |
| 12 | BRIDGEBIO PHARMA INC COM | $63.1M | 850.0K | 3.2% | REDUCED | -350,000 |
| 13 | OLEMA PHARMACEUTICALS INC COM | $58.1M | 3.90M | 2.9% | ADDED | +1.15M |
| 14 | BIOAGE LABS INC COM | $50.6M | 2.89M | 2.5% | ADDED | +850.0K |
| 15 | CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $41.7M | 1.05M | 2.1% | REDUCED | -275,000 |
| 16 | DAMORA THERAPEUTICS INC COM NEW | $39.5M | 1.52M | 2.0% | NEW | — |
| 17 | MBX BIOSCIENCES INC COM | $33.4M | 1.12M | 1.7% | —HELD | 0 |
| 18 | INSMED INC COM PAR $.01 | $31.1M | 190.0K | 1.6% | REDUCED | -85,000 |
| 19 | NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | $30.4M | 950.0K | 1.5% | REDUCED | -50,000 |
| 20 | TANGO THERAPEUTICS INC COM | $29.8M | 1.43M | 1.5% | NEW | — |
| 21 | PHARVARIS N V COM | $28.3M | 1.00M | 1.4% | REDUCED | -83,000 |
| 22 | ORUKA THERAPEUTICS INC COM | $26.2M | 533.3K | 1.3% | —HELD | 0 |
| 23 | AGOMAB THERAPEUTICS NV SPONSORED ADS | $25.9M | 2.47M | 1.3% | NEW | — |
| 24 | MAZE THERAPEUTICS INC COM | $22.4M | 750.0K | 1.1% | NEW | — |
| 25 | CORBUS PHARMACEUTICALS HLDGS COM NEW | $22.0M | 2.34M | 1.1% | —HELD | 0 |
Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.
Last filed: May 15, 2026